OrbiMed’s ImageneBio Inc IMA Stock Holding History

OrbiMed’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89M	Hold	378,556	–	–	0.04%	108
2025 Q4	$2.61M	Hold	378,556	–	–	0.05%	97
2025 Q3	$3.09M	Buy	378,556 +83,609	+28%	+$1.11M	0.07%	96
2025 Q2	$4.74M	Hold	294,947	–	–	0.12%	79
2025 Q1	$4.53M	Hold	294,947	–	–	0.11%	80
2024 Q4	$5.8M	Hold	294,947	–	–	0.12%	82
2024 Q3	$6.12M	Hold	294,947	–	–	0.11%	91
2024 Q2	$5.84M	Hold	294,947	–	–	0.12%	85
2024 Q1	$5.03M	Hold	294,947	–	–	0.09%	96
2023 Q4	$6.97M	Buy	294,947 +29,433	+11%	+$960K	0.14%	86
2023 Q3	$13.8M	Hold	265,514	–	–	0.29%	71
2023 Q2	$20.9M	Hold	265,514	–	–	0.38%	69
2023 Q1	$11M	Buy	265,514 +21,019	+9%	+$966K	0.22%	83
2022 Q4	$7.8M	Hold	244,495	–	–	0.15%	83
2022 Q3	$10.4K	Hold	244,495	–	–	0.19%	83
2022 Q2	$13K	Hold	244,495	–	–	0.24%	79
2022 Q1	$17.9M	Hold	244,495	–	–	0.29%	70
2021 Q4	$36.8M	Hold	244,495	–	–	0.47%	59
2021 Q3	$37M	Hold	244,495	–	–	0.41%	69
2021 Q2	$41.2M	Hold	244,495	–	–	0.42%	66
2021 Q1	$82.9M	Buy	+244,495	New	+$83.7M	0.78%	39

Other funds holding IMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OrbiMed's IMA Position: Q1 2026 in Review

OrbiMed held its ImageneBio Inc (IMA) position steady in Q1 2026 at 378,556 shares worth $1.89M. The position accounts for 0.04% of the portfolio, ranked #108.

OrbiMed first reported a position in IMA in Q1 2021 and has held it in 21 quarters since. The position peaked at $82.9M in Q1 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

OrbiMed held 378,556 shares of ImageneBio Inc worth $1.89M as of Q1 2026.
OrbiMed left its ImageneBio Inc share count unchanged in Q1 2026.
ImageneBio Inc made up 0.04% of OrbiMed's portfolio in Q1 2026, its #108 holding.
OrbiMed first reported a position in ImageneBio Inc in Q1 2021 and has held it in 21 quarters since.
OrbiMed's ImageneBio Inc position peaked at $82.9M in Q1 2021.
39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.